Misplaced Pages

#568431

52-458: Glucagon-like peptide-1 ( GLP-1 ) is a 30- or 31-amino-acid-long peptide hormone deriving from the tissue-specific posttranslational processing of the proglucagon peptide. It is produced and secreted by intestinal enteroendocrine L-cells and certain neurons within the nucleus of the solitary tract in the brainstem upon food consumption. The initial product GLP-1 (1–37) is susceptible to amidation and proteolytic cleavage , which gives rise to

104-421: A half-life of approximately 2 minutes. Consequently, only 10–15 % of GLP-1 reaches circulation intact, leading to fasting plasma levels of only 0–15 pmol/L. To overcome this, GLP-1 receptor agonists and DPP-4 inhibitors have been developed to increase GLP-1 activity. As opposed to common treatment agents such as insulin and sulphonylurea , GLP-1-based treatment has been associated with weight loss and

156-436: A buffering agent, maintaining pH and preventing sample damage during electrophoresis. Glycine is also used to remove protein-labeling antibodies from Western blot membranes to enable the probing of numerous proteins of interest from SDS-PAGE gel. This allows more data to be drawn from the same specimen, increasing the reliability of the data, reducing the amount of sample processing, and number of samples required. This process

208-535: A direct effect cannot be completely excluded. In the brain, GLP-1 receptor activation has been linked with neurotrophic effects including neurogenesis and neuroprotective effects including reduced necrotic and apoptotic signaling, cell death , and dysfunctions. In the diseased brain, GLP-1 receptor agonist treatment is associated with protection against a range of experimental disease models such as Parkinson's disease , Alzheimer's disease , stroke, traumatic brain injury , and multiple sclerosis . In accordance with

260-480: A lower risk of hypoglycemia , two important considerations for patients with type 2 diabetes. The proglucagon gene is expressed in several organs including the pancreas ( α-cells of the islets of Langerhans ), gut (intestinal enteroendocrine L-cells) and brain (caudal brainstem and hypothalamus ). Pancreatic proglucagon gene expression is promoted upon fasting and hypoglycaemia induction and inhibited by insulin. Conversely, intestinal proglucagon gene expression

312-592: A similar fashion to peptide hormones, and some " neuropeptides " may be used as neurotransmitters in the nervous system in addition to acting as hormones when released into the blood. When a peptide hormone binds to a receptor on the surface of the cell, a second messenger appears in the cytoplasm , which triggers signal transduction leading to the cellular responses. Some peptides ( angiotensin II , basic fibroblast growth factor -2, parathyroid hormone-related protein ) also interact with intracellular receptors located in

364-447: A subject of intensive investigation as a potential treatment of diabetes mellitus , as these actions induce long-term improvements along with the immediate effects. Although reduced GLP-1 secretion has previously been associated with attenuated incretin effect in patients with type 2 diabetes , it is now granted that GLP-1 secretion in patients with type 2 diabetes does not differ from healthy subjects. The most noteworthy effect of GLP-1

416-465: Is Cu(glycinate) 2 , i.e. Cu(H 2 NCH 2 CO 2 ) 2 , which exists both in cis and trans isomers. With acid chlorides, glycine converts to the amidocarboxylic acid, such as hippuric acid and acetylglycine . With nitrous acid , one obtains glycolic acid ( van Slyke determination ). With methyl iodide , the amine becomes quaternized to give trimethylglycine , a natural product: Glycine condenses with itself to give peptides, beginning with

468-506: Is a membrane-bound zinc metallopeptidase widely expressed in several tissues, but found in particularly high concentrations in the kidneys , which is also identified accountable for the rapid degradation of GLP-1. It primarily cleaves peptides at the N-terminal side of aromatic amino acids or hydrophobic amino acids and is estimated to contribute by up to 50% of the GLP-1 degradation. However,

520-438: Is also co-generated as an impurity in the synthesis of EDTA , arising from reactions of the ammonia co-product. Its acid–base properties are most important. In aqueous solution, glycine is amphoteric : below pH = 2.4, it converts to the ammonium cation called glycinium. Above about pH 9.6, it converts to glycinate. Glycine functions as a bidentate ligand for many metal ions, forming amino acid complexes . A typical complex

572-479: Is an inhibitory neurotransmitter in the central nervous system , especially in the spinal cord , brainstem , and retina . When glycine receptors are activated, chloride enters the neuron via ionotropic receptors, causing an inhibitory postsynaptic potential (IPSP). Strychnine is a strong antagonist at ionotropic glycine receptors, whereas bicuculline is a weak one. Glycine is a required co-agonist along with glutamate for NMDA receptors . In contrast to

SECTION 10

#1732859541569

624-693: Is another attractive property regarding diabetes treatment. However, these gastrointestinal activities are also the reason why subjects treated with GLP-1-based agents occasionally experience nausea . GLP-1 has also shown signs of carrying out protective and regulatory effects in numerous other tissues, including heart, tongue, adipose, muscles, bones, kidneys, liver and lungs. In the early 1980s, Richard Goodman and P. Kay Lund were postdoctoral researchers working in Joel Habener 's laboratory at Massachusetts General Hospital . Starting in 1979, Goodman harvested DNA from American anglerfish islet cells and spliced

676-639: Is as a flavorant. It is mildly sweet, and it counters the aftertaste of saccharine . It also has preservative properties, perhaps owing to its complexation to metal ions. Metal glycinate complexes, e.g. copper(II) glycinate are used as supplements for animal feeds. As of 1971 , the U.S. Food and Drug Administration "no longer regards glycine and its salts as generally recognized as safe for use in human food", and only permits food uses of glycine in certain conditions. Glycine has been researched for its potential to extend life . The proposed mechanisms of this effect are its ability to clear methionine from

728-461: Is catalyzed by glycine synthase (also called glycine cleavage enzyme). This conversion is readily reversible : In addition to being synthesized from serine, glycine can also be derived from threonine , choline or hydroxyproline via inter-organ metabolism of the liver and kidneys. Glycine is degraded via three pathways. The predominant pathway in animals and plants is the reverse of the glycine synthase pathway mentioned above. In this context,

780-507: Is expressed on the surface of endothelial cells , including those located directly adjacent to GLP-1 secretion sites. Consequently, less than 25% of secreted GLP-1 is estimated to leave the gut intact. Additionally, presumably due to the high concentration of DPP-4 found on hepatocytes , 40–50% of the remaining active GLP-1 is degraded across the liver . Thus, due to the activity of DPP-4 only 10–15 % of secreted GLP-1 reaches circulation intact. Neutral endopeptidase 24.11 (NEP 24.11)

832-431: Is extremely susceptible to the catalytic activity of the proteolytic enzyme dipeptidyl peptidase-4 ( DPP-4 ). Specifically, DPP-4 cleaves the peptide bond between Ala - Glu resulting in the abundant GLP-1 (9–36) amide constituting 60–80 % of total GLP-1 in circulation. DPP-4 is widely expressed in multiple tissues and cell types and exists in both a membrane-anchored and soluble circulating form. Notably, DPP-4

884-428: Is highly interesting regarding diabetes treatment. Considered almost as important as the effect of enhancing insulin secretion, GLP-1 has been shown to inhibit glucagon secretion at glucose levels above fasting levels. Critically, this does not affect the glucagon response to hypoglycemia as this effect is also glucose-dependent. The inhibitory effect is presumably mediated indirectly through somatostatin secretion, but

936-551: Is integral to the formation of alpha-helices in secondary protein structure due to the "flexibility" caused by such a small R group. Glycine is also an inhibitory neurotransmitter – interference with its release within the spinal cord (such as during a Clostridium tetani infection) can cause spastic paralysis due to uninhibited muscle contraction. It is the only achiral proteinogenic amino acid . It can fit into hydrophilic or hydrophobic environments, due to its minimal side chain of only one hydrogen atom. Glycine

988-490: Is its ability to promote insulin secretion in a glucose-dependent manner. As GLP-1 binds to GLP-1 receptors expressed on the pancreatic β cells , the receptors couple to G-protein subunits and activate adenylate cyclase that increases the production of cAMP from ATP . Subsequently, activation of secondary pathways, including PKA and Epac2 , alters the ion channel activity causing elevated levels of cytosolic Ca that enhances exocytosis of insulin-containing granules. During

1040-582: Is known as stripping. The presence of glycine outside the Earth was confirmed in 2009, based on the analysis of samples that had been taken in 2004 by the NASA spacecraft Stardust from comet Wild 2 and subsequently returned to Earth. Glycine had previously been identified in the Murchison meteorite in 1970. The discovery of glycine in outer space bolstered the hypothesis of so-called soft-panspermia , which claims that

1092-414: Is not essential to the human diet , as it is biosynthesized in the body from the amino acid serine , which is in turn derived from 3-phosphoglycerate . In most organisms, the enzyme serine hydroxymethyltransferase catalyses this transformation via the cofactor pyridoxal phosphate : In E. coli , glycine is sensitive to antibiotics that target folate. In the liver of vertebrates , glycine synthesis

SECTION 20

#1732859541569

1144-514: Is not used for industrial production, as it can be manufactured more conveniently by chemical synthesis. The two main processes are amination of chloroacetic acid with ammonia , giving glycine and hydrochloric acid , and the Strecker amino acid synthesis , which is the main synthetic method in the United States and Japan. About 15 thousand tonnes are produced annually in this way. Glycine

1196-402: Is reduced during fasting and stimulated upon food consumption. In mammals, the transcription gives rise to identical mRNA in all three cell types, which is further translated to the 180 amino acid precursor called proglucagon . However, as a result of tissue-specific posttranslational processing mechanisms, different peptides are produced in the different cells. In the pancreas ( α-cells of

1248-459: Is then excreted. The metabolic pathway for this begins with the conversion of benzoate by butyrate-CoA ligase into an intermediate product, benzoyl-CoA , which is then metabolized by glycine N -acyltransferase into hippuric acid. In the US, glycine is typically sold in two grades: United States Pharmacopeia ("USP"), and technical grade. USP grade sales account for approximately 80 to 85 percent of

1300-506: Is then oxidized by hepatic lactate dehydrogenase to oxalate in an NAD -dependent reaction. The half-life of glycine and its elimination from the body varies significantly based on dose. In one study, the half-life varied between 0.5 and 4.0 hours. The principal function of glycine is it acts as a precursor to proteins . Most proteins incorporate only small quantities of glycine, a notable exception being collagen , which contains about 35% glycine due to its periodically repeated role in

1352-720: Is therefore an important aspect to consider, as it regulates the entry of nutrients into the small intestines where the direct stimulation occurs. One of the actions of GLP-1 is to inhibit gastric emptying , thus slowing down its own secretion upon postprandial activation. Fasting plasma concentration of biologically active GLP-1 range between 0 and 15 pmol/L in humans and is increased 2- to 3-fold upon food consumption depending on meal size and nutrient composition. Individual nutrients, such as fatty acids , essential amino acids and dietary fibre have also shown to stimulate GLP-1 secretion. Sugars have been associated with various signalling pathways , which initiate depolarisation of

1404-576: The Swedish chemist Berzelius suggested the simpler current name a year later. The name comes from the Greek word γλυκύς "sweet tasting" (which is also related to the prefixes glyco- and gluco- , as in glycoprotein and glucose ). In 1858, the French chemist Auguste Cahours determined that glycine was an amine of acetic acid . Although glycine can be isolated from hydrolyzed proteins , this route

1456-635: The cell nucleus . Preprohormones , peptide hormone precursors, are then processed in several stages, typically in the endoplasmic reticulum , including removal of the N-terminal signal sequence and sometimes glycosylation , resulting in prohormones . The prohormones are then packaged into membrane-bound secretory vesicles , which can be secreted from the cell by exocytosis in response to specific stimuli (e.g. an increase in Ca and cAMP concentration in cytoplasm). These prohormones often contain superfluous amino acid residues that were needed to direct folding of

1508-440: The cytoplasm or nucleus by an intracrine mechanism. Glycine Glycine (symbol Gly or G ; / ˈ ɡ l aɪ s iː n / ) is an amino acid that has a single hydrogen atom as its side chain . It is the simplest stable amino acid ( carbamic acid is unstable). Glycine is one of the proteinogenic amino acids . It is encoded by all the codons starting with GG (GGU, GGC, GGA, GGG). Glycine

1560-463: The islets of Langerhans ), proglucagon is cleaved by prohormone convertase (PC) 2 producing glicentin-related pancreatic peptide (GRPP), glucagon , intervening peptide-1 (IP-1) and major proglucagon fragment (MPGF). In the gut and brain, proglucagon is catalysed by PC 1/3 giving rise to glicentin, which may be further processed to GRPP and oxyntomodulin , GLP-1, intervening peptide-2 (IP-2) and glucagon-like peptide-2 ( GLP-2 ). Initially, GLP-1

1612-437: The jejunum and duodenum . The L-cells are open-type triangular epithelial cells directly in contact with the lumen and neuro-vascular tissue and are accordingly stimulated by various nutrient , neural and endocrine factors. GLP-1 is released in a biphasic pattern with an early phase after 10–15 minutes followed by a longer second phase after 30–60 minutes upon meal ingestion. As the majority of L-cells are located in

Glucagon-like peptide-1 - Misplaced Pages Continue

1664-515: The secretion of insulin . Beside the insulinotropic effects, GLP-1 has been associated with numerous regulatory and protective effects. Unlike GIP, the action of GLP-1 is preserved in patients with type 2 diabetes . Glucagon-like peptide-1 receptor agonists gained approval as drugs to treat diabetes and obesity starting in the 2000s. Endogenous GLP-1 is rapidly degraded primarily by dipeptidyl peptidase-4 (DPP-4), as well as neutral endopeptidase 24.11 (NEP 24.11) and renal clearance , resulting in

1716-574: The "building blocks" of life are widespread throughout the universe. In 2016, detection of glycine within Comet 67P/Churyumov–Gerasimenko by the Rosetta spacecraft was announced. The detection of glycine outside the Solar System in the interstellar medium has been debated. Glycine is proposed to be defined by early genetic codes. For example, low complexity regions (in proteins), that may resemble

1768-763: The 1980s, Svetlana Mojsov worked on the identification of GLP-1 at Mass General, where she was head of a peptide synthesis facility. To try to identify whether a specific fragment of GLP-q was an incretin, Mojsov created an incretin-antibody and developed ways to track its presence. She identified that a stretch of 31 amino acids in the GLP-1 was an incretin. Mojsov and her collaborators Daniel J. Drucker and Habener showed that small quantities of lab-synthesized GLP-1 could trigger insulin. Mojsov fought to have her name included in patents, with Mass General eventually agreeing to amend four patents to include her name. She received her one-third of drug royalties for one year. The discovery of GLP-1's extremely short half-life meant that it

1820-568: The DNA into bacteria to find the gene for somatostatin , then Lund joined the Habener lab and used Goodman's bacteria to search for the gene for glucagon. In 1982, they published their discovery that the gene for proglucagon actually codes for three peptides: glucagon and two novel peptides. Those two novel peptides were later isolated, identified, and investigated by other researchers, and are now known as glucagon-like peptide-1 and glucagon-like peptide-2. In

1872-478: The L-cell membrane causing an elevated concentration of cytosolic Ca which in turn induce GLP-1 secretion. Fatty acids have been associated with the mobilisation of intracellular Ca stores and subsequently release of Ca into the cytosol . The mechanisms of protein-triggered GLP-1 secretion are less clear, but the amino acid proportion and composition appear important to the stimulatory effect. Once secreted, GLP-1

1924-541: The U.S. market for glycine. If purity greater than the USP standard is needed, for example for intravenous injections, a more expensive pharmaceutical grade glycine can be used. Technical grade glycine, which may or may not meet USP grade standards, is sold at a lower price for use in industrial applications, e.g., as an agent in metal complexing and finishing. Glycine is not widely used in foods for its nutritional value, except in infusions. Instead, glycine's role in food chemistry

1976-500: The activity only becomes apparent once the degradation of DPP-4 has been prevented, as the majority of GLP-1 reaching the kidneys have already been processed by DPP-4 . Similarly, renal clearance appear more significant for the elimination of already inactivated GLP-1. The resulting half-life of active GLP-1 is approximately 2 minutes, which is however sufficient to activate GLP-1 receptors . GLP-1 possesses several physiological properties making it (and its functional analogs )

2028-483: The body, and activating autophagy . Glycine is an intermediate in the synthesis of a variety of chemical products. It is used in the manufacture of the herbicides glyphosate , iprodione , glyphosine, imiprothrin , and eglinazine. It is used as an intermediate of antibiotics such as thiamphenicol . Glycine is a significant component of some solutions used in the SDS-PAGE method of protein analysis. It serves as

2080-454: The distal ileum and colon, the early phase is likely explained by neural signalling, gut peptides or neurotransmitters . Other evidence suggest that the amount of L-cells located in the proximal jejunum is sufficient to account for the early phase secretion through direct contact with luminal nutrients. Less controversially, the second phase is likely caused by direct stimulation of L-cells by digested nutrients . The rate of gastric emptying

2132-423: The enzyme system involved is usually called the glycine cleavage system : In the second pathway, glycine is degraded in two steps. The first step is the reverse of glycine biosynthesis from serine with serine hydroxymethyl transferase. Serine is then converted to pyruvate by serine dehydratase . In the third pathway of its degradation, glycine is converted to glyoxylate by D-amino acid oxidase . Glyoxylate

Glucagon-like peptide-1 - Misplaced Pages Continue

2184-521: The expression of GLP-1 receptor on brainstem and hypothalamus, GLP-1 has been shown to promote satiety and thereby reduce food and water intake. Consequently, diabetic subjects treated with GLP-1 receptor agonists often experience weight loss as opposed to the weight gain commonly induced with other treatment agents. In the stomach, GLP-1 inhibits gastric emptying, acid secretion and motility, which collectively decrease appetite. By decelerating gastric emptying GLP-1 reduces postprandial glucose excursion which

2236-478: The formation of glycylglycine : Pyrolysis of glycine or glycylglycine gives 2,5-diketopiperazine , the cyclic diamide. Glycine forms esters with alcohols . They are often isolated as their hydrochloride , such as glycine methyl ester hydrochloride . Otherwise, the free ester tends to convert to diketopiperazine . As a bifunctional molecule, glycine reacts with many reagents. These can be classified into N-centered and carboxylate-center reactions. Glycine

2288-428: The formation of collagen's helix structure in conjunction with hydroxyproline . In the genetic code , glycine is coded by all codons starting with GG, namely GGU, GGC, GGA and GGG. In higher eukaryotes , δ-aminolevulinic acid , the key precursor to porphyrins , is biosynthesized from glycine and succinyl-CoA by the enzyme ALA synthase . Glycine provides the central C 2 N subunit of all purines . Glycine

2340-488: The hormone molecule into its active configuration but have no function once the hormone folds. Specific endopeptidases in the cell cleave the prohormone just before it is released into the bloodstream , generating the mature hormone form of the molecule. Mature peptide hormones then travel through the blood to all of the cells of the body, where they interact with specific receptors on the surfaces of their target cells. Some neurotransmitters are secreted and released in

2392-630: The inhibitory role of glycine in the spinal cord, this behaviour is facilitated at the ( NMDA ) glutamatergic receptors which are excitatory. The LD 50 of glycine is 7930 mg/kg in rats (oral), and it usually causes death by hyperexcitability. Glycine conjugation pathway has not been fully investigated. Glycine is thought to be a hepatic detoxifier of a number endogenous and xenobiotic organic acids. Bile acids are normally conjugated to glycine in order to increase their solubility in water. The human body rapidly clears sodium benzoate by combining it with glycine to form hippuric acid which

2444-485: The process, influx of glucose ensures sufficient ATP to sustain the stimulatory effect. Additionally, GLP-1 ensures the β cell insulin stores are replenished to prevent exhaustion during secretion by promoting insulin gene transcription, mRNA stability and biosynthesis. GLP-1 evidently also increases β cell mass by promoting proliferation and neogenesis while inhibiting apoptosis . As both type 1 and 2 diabetes are associated with reduction of functional β cells, this effect

2496-422: The two truncated and equipotent biologically active forms, GLP-1 (7–36) amide and GLP-1 (7–37). Active GLP-1 protein secondary structure includes two α-helices from amino acid position 13–20 and 24–35 separated by a linker region. Alongside glucose-dependent insulinotropic peptide (GIP), GLP-1 is an incretin ; thus, it has the ability to decrease blood sugar levels in a glucose-dependent manner by enhancing

2548-463: Was discovered in 1820 by French chemist Henri Braconnot when he hydrolyzed gelatin by boiling it with sulfuric acid . He originally called it "sugar of gelatin", but French chemist Jean-Baptiste Boussingault showed in 1838 that it contained nitrogen. In 1847 American scientist Eben Norton Horsford , then a student of the German chemist Justus von Liebig , proposed the name "glycocoll"; however,

2600-494: Was found to serve as a substrate for amidation of the C-terminal arginine resulting in the equally potent GLP-1 (7–36) amide. In humans, almost all (>80%) secreted GLP-1 is amidated, whereas a considerable part remains GLP-1 (7–37) in other species. GLP-1 is packaged in secretory granules and secreted into the hepatic portal system by the intestinal L-cells located primarily in the distal ileum and colon, but also found in

2652-504: Was impossible to develop into a drug. This caused diabetes research to shift towards other therapeutic options such as targeting the GLP-1 receptor, which then led to the development of GLP-1 receptor agonists. American diabetes association:link- http://diabetes.diabetesjournals.org/content/56/1/8.full Peptide hormone Like all peptides, peptide hormones are synthesized in cells from amino acids according to mRNA transcripts, which are synthesized from DNA templates inside

SECTION 50

#1732859541569

2704-467: Was thought to correspond to proglucagon (72–108) suitable with the N-terminal of the MPGF, but sequencing experiments of endogenous GLP-1 revealed a structure corresponding to proglucagon (78–107) from which two discoveries were found. Firstly, the full-length GLP-1 (1–37) was found to be catalysed by endopeptidase to the biologically active GLP-1 (7–37). Secondly, the glycine corresponding to proglucagon(108)

#568431